Aniruddha Sasmal

Dr. Aniruddha Sasmal

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CDChirag Dhar
Chirag Dhar
ASAniruddha Sasmal
Aniruddha Sasmal
AVAjit Varki
Ajit Varki
The description of “serum sickness” more than a century ago in humans transfused with animal sera eventually led to identification of a class of human antibodies directed against glycans terminating in the common mammalian sialic acid N-Glycolylneuraminic acid (Neu5Gc), hereafter called “Neu5Gc-glycans.” The detection of such glycans in malignant and fetal human tissues initially raised the possibility that it was an oncofetal antigen. However, “serum sickness” antibodies were also noted in various human disease states. These findings spurred further research on Neu5Gc, and the discovery that it is not synthesized in the human body due to a human-lineage specific genetic mutation in the enzyme CMAH. However, with more sensitive techniques Neu5Gc-glycans were detected in smaller quantities on certain human cell types, particularly epithelia and endothelia. The likely explanation is metabolic incorporation of Neu5Gc from dietary sources, especially red meat of mammalian origin. This incorporated Neu5Gc on glycans appears to be the first example of a “xeno-autoantigen,” against which varying levels of “xeno-autoantibodies” are present in all humans. The resulting chronic inflammation or “xenosialitis” may have important implications in human health and disease, especially in conditions known to be aggravated by consumption of red meat. In this review, we will cover the early history of the discovery of “serum sickness” antibodies, the subsequent recognition that they were partly directed against Neu5Gc-glycans, the discovery of the genetic defect eliminating Neu5Gc production in humans, and the later recognition that this was not an oncofetal antigen but the first example of a “xeno-autoantigen.” Further, we will present comments about implications for disease risks associated with red meat consumption such as cancer and atherosclerosis. We will also mention the potential utility of these anti-Neu5Gc-glycan antibodies in cancer immunotherapy and provide some suggestions and perspectives for the future. Other reviews in this special issue cover many other aspects of this unusual pathological process, for which there appears to be no other described precedent.

4 October 2017 in ACS Sensors
Verified
Journal Article
Closed access
Zhongyu CaiZhongyu Cai
Zhongyu Cai
ASAniruddha Sasmal
Aniruddha Sasmal
XLXinyu Liu
Xinyu Liu
SASanford A. Asher
Sanford A. Asher

26 May 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CMCaicai Meng
Caicai Meng
ASAniruddha Sasmal
Aniruddha Sasmal
YZYan Zhang
Yan Zhang
TGTian Gao
Tian Gao
CLChang‐Cheng Liu
Chang‐Cheng Liu
HCHongzhi Cao
Hongzhi Cao

7 March 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
NLNa Lu
Na Lu
JYJinfeng Ye
Jinfeng Ye
JCJiansong Cheng
Jiansong Cheng
ASAniruddha Sasmal
Aniruddha Sasmal
CLChang-Cheng Liu
Chang-Cheng Liu
HCHongzhi Cao
Hongzhi Cao

1 March 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
KKKunio Kawanishi
Kunio Kawanishi
SSSudeshna Saha
Sudeshna Saha
SDSandra Diaz
Sandra Diaz
MVMichael Vaill
Michael Vaill
ASAniruddha Sasmal
Aniruddha Sasmal
AVAjit Varki
Ajit Varki
Human metabolic incorporation of nonhuman sialic acid (Sia) N-glycolylneuraminic acid into endogenous glycans generates inflammation via preexisting antibodies, which likely contributes to red meat–induced atherosclerosis acceleration. Exploring whether this mechanism affects atherosclerosis in end-stage renal disease (ESRD), we instead found serum accumulation of 2-keto-3-deoxy-d-glycero-d-galacto-2-nonulosonic acid (Kdn), a Sia prominently expressed in cold-blooded vertebrates. In patients with ESRD, levels of the Kdn precursor mannose also increased, but within a normal range. Mannose ingestion by healthy volunteers raised the levels of urinary mannose and Kdn. Kdn production pathways remained conserved in mammals but were diminished by an M42T substitution in a key biosynthetic enzyme, N-acetylneuraminate synthase. Remarkably, reversion to the ancestral methionine then occurred independently in 2 lineages, including humans. However, mammalian glycan databases contain no Kdn-glycans. We hypothesize that the potential toxicity of excess mannose in mammals is partly buffered by conversion to free Kdn. Thus, mammals probably conserve Kdn biosynthesis and modulate it in a lineage-specific manner, not for glycosylation, but to control physiological mannose intermediates and metabolites. However, human cells can be forced to express Kdn-glycans via genetic mutations enhancing Kdn utilization, or by transfection with fish enzymes producing cytidine monophosphate–Kdn (CMP-Kdn). Antibodies against Kdn-glycans occur in pooled human immunoglobulins. Pathological conditions that elevate Kdn levels could therefore result in antibody-mediated inflammatory pathologies.

3 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SSShoib S. Siddiqui
Shoib S. Siddiqui
CDChirag Dhar
Chirag Dhar
VSVenkatasubramaniam Sundaramurthy
Venkatasubramaniam Sundaramurthy
ASAniruddha Sasmal
Aniruddha Sasmal
HYHai Yu
Hai Yu
AVAjit Varki
Ajit Varki
Significance: Sepsis is a condition wherein a microbial infection leads to life-threatening systemic hyperactivation of innate immunity. Blood pH is normally maintained tightly between 7.35 and 7.45, and lactic acidosis with a pH <7.3 indicates a poor prognosis in sepsis, also associated with low zinc levels. Release of HMGB1 from activated and/or necrotic tissues plays a pivotal role in triggering the proinflammatory cascade of late sepsis. Using an in vitro whole-blood assay, we observed that HMGB1 cannot mediate proinflammatory activity at physiological pH and zinc concentrations. This is due to zinc-dependent association of HMGB1 with sialoglycoproteins, thereby preventing its binding with proinflammatory receptors. Thus, a drop in pH and zinc concentration in sepsis can release sequestered HMGB1 and trigger the inflammatory cascade.